{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XLkSXerWt1\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23517\/\">2001\u5e748\u67083\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/23517\/embed\/#?secret=XLkSXerWt1\" width=\"600\" height=\"338\" title=\"\u300a Animal Health News &#038; Notes for August 3, 2001 \u300b\u2014Brakke Consulting Website\" data-secret=\"XLkSXerWt1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for August 3, 2001 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt;&nbsp; Aventis reported that in the first half of 2001, sales by the animal health business Merial rose 10% to &euro; 944 million ($800 million).&nbsp; This figure includes the poultry genetics business. (company press release) &gt;&nbsp; Akzo Nobel reported revenues for Intervet for the second quarter of 2001 were &euro; 282 million ($240 million), an increase of 12% over the second quarter of 2000.&nbsp; Revenues for the first half of 2001 were &euro; 539 million ($460 million), an increase of 10% over the first half of 2000.&nbsp; (company website) &gt;&nbsp; Alpharma Inc. announced financial results for the second quarter and six months ended June 30, 2001. Animal Pharmaceuticals revenue was basically flat in the second quarter at $81.7 million when compared to the same period last year.&nbsp; Significant increases in swine product sales were offset by declines in poultry product sales.&nbsp; Conditions in the U.S. poultry market, including the impact of reduced customer inventory levels, together with softness in Asian markets, were the cause of the decline.&nbsp; This mix resulted in operating income of $9.2 million, 25% lower than the prior year period.&nbsp; For the six months ended June 30, 2001, Animal Pharmaceuticals revenue was $165.2 million, an increaseView Full Post;"}